Comparison of the effect of two therapies methylphenidate and matrix-methylphenidate in methamphetamine abusers

Not Applicable

Conditions: F15.15
Other stimulant abuse with stimulant-induced psychotic disorder
Methamphetamine Dependency.

Registration Number: IRCT20171105037245N1

Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 100

Inclusion Criteria

being at the age of 20 to 48 years
Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
The dominant use of methamphetamine
Seeking treatment for methamphetamine abuse

Exclusion Criteria

Unwillingness to participate in the study
Having severe psychotic disorders
Suicide attempts within the past 12 months
Major cardiovascular disorder
Epilepsy
Current alcohol or sedative physical dependence or cocaine dependence

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Addiction Severity. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Addiction Severity Index.;Craving. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Desire for Drug Questionnaire (DDQ craving).

Secondary Outcome Measures

Name	Time	Method
Mental health. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: General Health Questionnaire (GHQ).;Negative urine test for methamphetamine. Timepoint: Before intervention and 3, 6, 9 and 12 weeks after intervention. Method of measurement: Methamphetamine urine test.